Crystal modifications and dissolution rate of piroxicam

A. Rajendarn and S. K. Basu, Crystal modification of dipyridamole using different solvents and crystallization conditions, Int. J. Pharm. 321 (2006) 27-34; DOI: 10.1016/J.IJPHARM.2006.04.021.10.1016/j.ijpharm.2006.04.021Search in Google Scholar

N. Blagden, M. de Matas, P. T. Gavan and P. York, Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates, Adv. Drug Del. Rev. 59 (2007) 617-630; DOI: 10.1016/J.ADDR.2007.05.011.10.1016/j.addr.2007.05.011Search in Google Scholar

S. R. Byrn, R. R. Pfeiffer, G. Stephenson, D. J. W. Grant and W. B. Gleason, Solid state pharmaceutical chemistry, Chem. Mater. 6 (1994) 1148; DOI: 10.1021/cm00044a013.10.1021/cm00044a013Search in Google Scholar

M. El-Baldry, G. Fetih and M. Fathy, Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG 4000, Saudi Pharm. J. 17 (2009) 219-229; DOI: 10.1016/J.JSPS.2009.08.006.10.1016/j.jsps.2009.08.006Search in Google Scholar

M. Fernandez, I. C. Rodriguez and A. Crezo, Characterization of solid dispersions of piroxicam/polyethylene glycol 4000, Int. J. Pharm. 84 (1992) 197-202; DOI: 10.1016/0378-5173(92)90060-F.10.1016/0378-5173(92)90060-FSearch in Google Scholar

D. Horter and J. B. Dressman, Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract, Adv. Drug Del Rev. 25 (1997) 3-14; DOI: 10.1016/S0169-409X (00) 00130-7.Search in Google Scholar

P. B. Myrdal and M. J. Jozwiakowski, Water-Insoluble Drug Formulation, in Alteration of the Solid State of the Drug Substances: Polymorphs, Solvates, and Amorphous Forms, 2^nd ed. (Ed. R. Lin), AustarPharma, Edison (NJ), 2008.10.1201/9781420009552.ch19Search in Google Scholar

M. C. Martinez-Oharriz, C. Martýn, M. M. Goni, C. Rodrýguez-Espinosa, A. Zornoza and M. C. Tros-Ilarduya, Influence of polyethylene glycol 4000 on the polymorphic forms of diflunisal, Eur. J. Pharm. Sci. 8 (1999) 127-132; DOI: 10.1016/S0928-0987(99)00006-8.10.1016/S0928-0987(99)00006-8Search in Google Scholar

M. Mihalić, H. Hofman, J. Kuftinec, B. Krile, M. Zinic, F. Kajfez and N. Blazevic, Physicochemical and analytical characteristics of piroxicam, Acta Pharm. Jugosl. 32 (1982) 13-20.Search in Google Scholar

K. Srinivasan, K. Sankaranarayanan, S. Thangavelu and P. Ramasamy, Influence of organic solvents on the habit of NMBA (4-nitro-4'-methyl benzylidene aniline) crystals, J. Cryst. Grow. 212 (2000) 246-54; DOI: 10.1016/S0022-0248(00)00300-6.10.1016/S0022-0248(00)00300-6Search in Google Scholar

V. Tantishaiyakul, N. Kaewnopparat and S. Ingkatawornwong, Properties of solid dispersion of piroxicam in polyvinylpyrrodine, Int. J. Pharm. Sci. 181 (1999) 143-51; DOI: 10.1016/S0378-5173(96)04687-X.10.1016/S0378-5173(96)04687-XSearch in Google Scholar

S. Verheyen, N. Blaton, R. Kinget and G. Van den Mooter, Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions, Int. J. Pharm. 249 (2002) 45-58; DOI: 10.1016/S0378-5173(02)00532-X.10.1016/S0378-5173(02)00532-XSearch in Google Scholar

F. Vrecer and S. Srcic, Investigation of piroxicam polymorphism, Int. J. Pharm. 68 (1990) 35-41; DOI: 10.1016/S0378-5173(03)00057-7.10.1016/S0378-5173(03)00057-7Search in Google Scholar

F. Vrečer, M. Vrbinc and A. Meden, Characterisation of piroxicam crystal modifications, Int. J. Pharm. 256 (2003) 3-15; DOI: 10.1016/S0378-5173(03)00057-7.10.1016/S0378-5173(03)00057-7Search in Google Scholar

United States Pharmacopoeia 24/National Formulary 19, USP Pharmacopoeial Convention, Rockville (MD) 2000.Search in Google Scholar